Minireview: The role of the autonomic nervous system in mediating the glucagon response to hypoglycemia.
In type 1 diabetes, the impairment of the glucagon response to hypoglycemia increases both its severity and duration. In nondiabetic individuals, hypoglycemia activates the autonomic nervous system, which in turn mediates the majority of the glucagon response to moderate and marked hypoglycemia. The first goal of this minireview is therefore to illustrate and document these autonomic mechanisms. Specifically we describe the hypoglycemic thresholds for activating the three autonomic inputs to the islet (parasympathetic nerves, sympathetic nerves, and adrenal medullary epinephrine) and their magnitudes of activation as glucose falls from euglycemia to near fatal levels. The implication is that their relative contributions to this glucagon response depend on the severity of hypoglycemia. The second goal of this minireview is to discuss known and suspected down-regulation or damage to these mechanisms in diabetes. We address defects in the central nervous system, the peripheral nervous system, and in the islet itself. They are categorized as either functional defects caused by glucose dysregulation or structural defects caused by the autoimmune attack of the islet. In the last section of the minireview, we outline approaches for reversing these defects. Such reversal has both scientific and clinical benefit. Scientifically, one could determine the contribution of these defects to the impairment of glucagon response seen early in type 1 diabetes. Clinically, restoring this glucagon response would allow more aggressive treatment of the chronic hyperglycemia that is linked to the debilitating long-term complications of this disease.
Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, Washington 98108, USA. taborsky@u.washington.edu
Gerald J
GJ
Taborsky
Thomas O
TO
Mundinger
D000818:Animals; D015551:Autoimmunity; D001341:Autonomic Nervous System / Q000502:physiology*; D002490:Central Nervous System / Q000378:metabolism; D003920:Diabetes Mellitus / Q000503:physiopathology; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism; D005786:Gene Expression Regulation; D005934:Glucagon / Q000737:chemistry* / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007003:Hypoglycemia / Q000378:metabolism*; D007333:Insulin Resistance; D007515:Islets of Langerhans / Q000166:cytology; D008954:Models, Biological; D017933:Peripheral Nervous System / Q000378:metabolism
D005934:Glucagon; D005947:Glucose